Marksans Pharma Limited

Web: marksanspharma.com NSE: MARKSANS BSE: 524404 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

247 6(2%)

Volume

49L as on 23, Jun

Open

294

High

300

Low

293

241

VWAP

264

52 Week High

282

52 Week Low

155

Viand Research Rating

Quality Score

74/100

Growth Score

48/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

11,193

No. of Shares

45.3

P/E

99.07

P/B

11.79

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

11.89

ROCE

Profit Growth

Listing Date

21-Jan-02

Promoter Holding

43.87%

FII Holding

16.76%

DII Holding

6.57%

Price Chart

Price Performance

1 Week8%

1 Month26%

3 Months66%

6 Months53%

1 Year53%

YTD53%

Moving Average

5 Day SMA260

10 Day SMA254

20 Day SMA249

30 Day SMA236

50 Day SMA216

61 Day SMA207

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	270	259	266	270
Resistance 2	266	258	262	266
Resistance 1	261	257	260	262
Pivot Point	257	256	257	257
Support 1	252	255	253	253
Support 2	248	254	251	248
Support 3	243	254	248	244

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,099	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,792	7300	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,70,907	5050	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,264	8851	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,12,694	1395	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,623	1109	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,686	2399	3%	3%	11%	25%	23	57.7	0.29	5355
8	MANKIND	1,05,603	2557	0%	0%	18%	3%	49	57.7	0.39	1938
9	MAXHEALTH	1,05,114	1080	2%	1%	8%	14%	0	57.7	0.32	1442
10	DRREDDY	97,638	1170	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.85%	(0.01) 43.85%	(0.01) 43.85%	(0.01) 43.85%	(-5.21) 43.85%	(0.41) 49.00%	(0.41) 48.60%	(0.01) 48.25%	(0.01) 48.25%	(0.01) 48.25%	(0.01) 48.25%
FIIs	(8.61) 16.76%	(-8.81) 8.13%	(-3.01) 16.92%	(-2.31) 19.89%	(0.21) 22.19%	(0.61) 21.95%	(2.71) 21.31%	(3.01) 18.59%	(0.01) 15.57%	(0.51) 15.55%	(0.21) 15.07%	(-0.21) 14.90%	(10.91) 15.11%	(0.21) 4.23%	(0.01) 4.06%	(0.61) 4.04%	(0.91) 3.46%	(-0.11) 2.59%	(0.01) 2.64%
DIIs	(0.71) 6.57%	(0.61) 5.91%	(-0.21) 5.28%	(1.01) 5.50%	(0.31) 4.55%	(0.21) 4.30%	(0.41) 4.10%	(-1.41) 3.75%	(0.41) 5.17%	(0.71) 4.76%	(0.41) 4.02%	(2.21) 3.65%	(0.51) 1.46%	(0.01) 0.96%	(0.01) 0.95%	(0.51) 0.94%	(0.11) 0.47%	(-0.11) 0.41%	(0.01) 0.53%
Public	32.78%	42.08%	33.93%	30.74%	29.37%	29.88%	30.70%	33.77%	35.40%	35.81%	37.06%	37.60%	39.57%	45.79%	46.38%	46.77%	47.82%	48.75%	48.58%
No. of Shareholders	246,279	255,153	265,788	256,221	257,273	259,813	248,845	235,500	254,699	237,377	207,937	188,447	198,382	213,123	217,743	221,359	220,090	214,998	201,451

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	856	754	720	620	708	682	642	591	560	586	531	500	486	480	453	434	418	363	361	349
Sales Growth % (YoY)	20.8%	10.6%	12.2%	5%	26.5%	16.3%	20.8%	18.1%	15.2%	22.2%	17.4%	15.3%	16.2%	32.3%	25.3%	24.3%	26.6%	1.2%	1.3%	5.4%
Sales Growth % (QoQ)	13.5%	4.7%	16.1%	-12.4%	3.8%	6.2%	8.6%	5.5%	-4.4%	10.4%	6.2%	2.9%	1.2%	6%	4.4%	3.8%	15.2%	0.6%	3.4%	-
Expenses	661	594	576	520	582	543	495	462	450	453	417	398	376	403	372	361	354	305	301	272
Operating Profit	195	161	144	100	127	139	147	128	110	133	114	102	110	77	80	73	64	58	60	77
OPM %	23	21	20	16	18	20	23	22	20	23	21	20	23	16	18	17	15	16	17	22
Other Income	35	20	22	6	15	28	0	15	17	5	19	10	11	18	14	16	15	12	9	6
Interest	6	6	6	6	3	3	3	3	5	3	2	2	2	2	3	2	5	1	2	1
Depreciation	24	24	27	23	23	21	20	20	21	22	18	14	14	13	14	11	21	9	7	7
Profit before tax	200	151	133	77	116	143	125	120	100	113	114	97	104	79	78	76	53	60	60	75
Tax %	25	25	26	24	22	27	22	26	23	26	26	27	21	21	23	21	44	20	23	16
Net Profit	149	114	99	58	91	105	98	89	78	83	84	70	83	62	60	60	30	48	46	63
Net Profit Growth % (QoQ)	30.7%	15.2%	70.7%	-36.3%	-13.3%	7.1%	10.1%	14.1%	-6%	-1.2%	20%	-15.7%	33.9%	3.3%	-	100%	-37.5%	4.3%	-27%	-
Net Profit Growth % (YoY)	63.7%	8.6%	1%	-34.8%	16.7%	26.5%	16.7%	27.1%	-6%	33.9%	40%	16.7%	176.7%	29.2%	30.4%	-4.8%	-	-	-	-
TTM Net Profit	420	362	353	352	383	370	348	334	315	320	299	275	265	212	198	184	187	157	109	0
EPS in Rs	3.27	2.5	2.17	1.29	2	2.31	2.13	1.96	1.73	1.84	1.84	1.52	1.81	1.57	1.51	1.46	0.69	1.18	1.11	1.53

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	2951	2623	2177	1852	1491	1376	1134	1000	913	767	893	797	630	438
Sales Growth %	12.5%	20.5%	17.6%	24.2%	8.3%	21.3%	13.4%	9.6%	19%	-14.1%	12.1%	26.5%	43.7%	23.3%
Expenses	2350	2094	1719	1513	1232	1037	942	868	834	722	757	612	512	369
Operating Profit	601	529	459	340	259	340	192	132	78	45	136	185	118	69
OPM %	20	20	21	18	17	25	17	13	9	6	15	23	19	16
Other Income	83	70	50	59	42	7	0	5	8	7	9	3	4	4
Interest	24	12	11	9	8	8	9	10	10	7	10	16	19	15
Depreciation	99	83	74	52	45	36	27	23	27	30	28	16	16	16
Profit before tax	561	504	424	338	248	302	157	104	50	15	107	156	86	44
Tax %	25	24	26	21	25	21	23	23	28	24	23	28	15	-12
Net Profit	420	383	315	265	187	239	121	80	36	11	83	112	74	49
Net Profit Growth %	9.7%	21.6%	18.9%	41.7%	-21.8%	97.5%	51.2%	122.2%	227.3%	-86.7%	-25.9%	51.4%	51%	-
EPS in Rs	9.22	8.4	6.92	5.88	4.51	5.76	2.95	1.87	0.8	0.22	1.92	2.67	1.87	1.19
Dividend Payout %	10	10	9	9	6	4	3	3	6	23	21	4	5	10

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	458	207	230	237	99	179	233	27	50	14	31	155	65	39
Cash from Investing Activity	-248	-49	-141	-259	-84	-45	-60	-13	-39	-21	-123	-33	-4	-5
Cash from Financing Activity	-71	-65	-69	198	80	-15	-114	-21	3	-3	-58	17	-29	-40
Net Cash Flow	139	93	21	176	94	118	60	-7	15	-10	-150	138	31	-7

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	45	45	45	45	45	45	41	41	41	41	41	41	41	41	39	39
Reserves	2978	2643	2422	2236	2020	1700	1161	846	595	502	430	392	401	326	90	34
Borrowings	343	332	322	198	244	123	111	34	30	100	118	110	100	101	173	176
Other Liabilities	494	422	451	432	372	322	323	307	236	160	142	209	180	207	188	152
Total Liabilities	3861	3442	3240	2911	2681	2190	1636	1228	902	802	731	752	722	676	490	401
Fixed Assets	1088	1054	982	787	776	486	428	309	303	270	279	267	270	166	146	156
CWIP	15	7	27	11	9	10	3	12	0	0	0	0	0	0	0	0
Investments	0	1	1	15	27	1	0	0	0	0	0	0	0	0	0	0
Other Assets	2758	2381	2230	2098	1869	1694	1205	907	599	533	451	484	452	510	344	245
Total Assets	3861	3442	3240	2911	2681	2190	1636	1228	902	802	731	752	722	676	490	401

Delivery

#	Date	197 43% 282	Value (Cr)	Q/T 70	Del 32	Del 57
1	22-Jul	241	104	70	37	39
2	21-Jul	260	55	47	45	24
3	20-Jul	267	20	24	48	10
4	17-Jul	267	38	39	43	16
5	16-Jul	275	35	40	46	16
6	15-Jul	276	47	66	39	18
7	14-Jul	271	39	62	42	16
8	13-Jul	269	30	63	46	14
9	10-Jul	272	60	70	52	31
10	9-Jul	277	126	77	40	50
11	8-Jul	263	101	77	38	39
12	7-Jul	261	41	46	47	19
13	6-Jul	260	36	63	43	15
14	3-Jul	264	35	52	44	15
15	2-Jul	267	36	47	41	15
16	1-Jul	269	52	58	41	21
17	30-Jun	273	69	80	44	30
18	29-Jun	263	58	82	34	20
19	25-Jun	256	37	66	44	16
20	24-Jun	263	103	89	30	31
21	23-Jun	266	131	74	30	39
22	22-Jun	256	41	76	36	14
23	19-Jun	260	63	82	31	19
24	18-Jun	261	129	88	33	43
25	17-Jun	255	38	80	42	16
26	16-Jun	247	50	75	32	16
27	15-Jun	250	41	49	42	17
28	12-Jun	252	64	61	34	22
29	11-Jun	250	93	79	26	24
30	10-Jun	247	61	69	35	21
31	9-Jun	253	170	96	32	55
32	8-Jun	236	67	74	30	20
33	5-Jun	233	41	57	40	16
34	4-Jun	239	37	52	46	17
35	3-Jun	242	66	50	40	26
36	2-Jun	241	65	53	40	26
37	1-Jun	239	76	73	34	26
38	29-May	246	166	93	22	36
39	27-May	249	377	102	17	64
40	26-May	255	943	116	11	106
41	25-May	220	40	66	43	17
42	22-May	212	29	71	45	13
43	21-May	216	22	61	34	8
44	20-May	217	45	78	33	15
45	19-May	217	66	77	34	23
46	18-May	218	137	87	24	32
47	15-May	207	81	101	34	27
48	14-May	202	29	61	32	9

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	11,193c	222c	2.02
22-Jul	10,971c	811c	6.88
21-Jul	11,782c	308c	2.55
17-Jul	12,090c	356c	2.86
16-Jul	12,446c	18c	0.15
15-Jul	12,464c	16c	0.13
14-Jul	12,448c	215c	1.76
13-Jul	12,233c	57c	0.46
10-Jul	12,290c	354c	2.80
09-Jul	12,643c	691c	5.78
08-Jul	11,952c	125c	1.05
07-Jul	11,828c	9c	0.08
06-Jul	11,819c	544c	4.40
02-Jul	12,362c	145c	1.16
30-Jun	12,507c	523c	4.36
29-Jun	11,984c	293c	2.50
26-Jun	11,692c	129c	1.12
25-Jun	11,563c	351c	2.95
24-Jun	11,914c	104c	0.87
23-Jun	12,018c	393c	3.38
22-Jun	11,625c	112c	0.95
19-Jun	11,737c	182c	1.57
17-Jun	11,555c	385c	3.44
16-Jun	11,171c	159c	1.40
15-Jun	11,329c	77c	0.68
12-Jun	11,406c	209c	1.79
11-Jun	11,615c	195c	1.71
10-Jun	11,420c	0	0

Stock Checklist

Price is above from 52 week high low average: 45%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 42 fund scheme(s) across 10 fund house(s) as of Jul26 · Total value ₹895 Cr · 8 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
UTI Mutual Fund	12	1.52%	-	421.2
Kotak Mahindra Mutual Fund	6	3.25%	+1.01%	280.9
Bandhan Mutual Fund	6	0.20%	-	130.3
Motilal Oswal Mutual Fund	4	0.30%	-	27.4
JM Financial Mutual Fund	2	1.14%	-	15.5
Old Bridge Mutual Fund	2	3.05%	+3.05%	12.8
Unifi Mutual Fund	2	1.18%	-	4.4
Groww Mutual Fund	4	1.76%	-	2.4
Angel One Mutual Fund	2	0.02%	-	0
Mirae Asset Mutual Fund	2	0.02%	-	0

Marksans Pharma Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements